Rosen Law Firm Urges Reckitt Benckiser Group PLC (OTC: RBGLY) Stockholders to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of American Depositary Shares ('ADSs') of Reckitt Benckiser Group PLC (OTC: RBGLY) between January 13, 2021 through July 28, 2024. Reckitt describes itself as a 'U.K.-based consumer goods and health conglomerate.'
For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.
The Allegations: Rosen Law Firm is Investigating the Allegations that Reckitt Benckiser Group PLC (OTC: RBGLY) Misled Investors Regarding its Business Operations.
According to the lawsuit, during the Class Period, defendants failed to warn investors and consumers: (1) that preterm infants were at an increased risk of developing necrotizing enterocolitis ('NEC') by consuming Reckitt's cow's milk-based formula, Enfamil; (2) of the attendant impact on Reckitt's sales of Enfamil and Reckitt's exposure to legal claims; and (3) as a result of the above, defendants' positive statements about Reckitt's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
What Now: You may be eligible to participate in the class action against Reckitt Benckiser Group PLC. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by August 4, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.
All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
About Rosen Law Firm: Some law firms issuing releases about this matter do not actually litigate securities class actions. Rosen Law Firm does. Rosen Law Firm is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses, improving corporate governance structures, and holding company executives accountable for their wrongdoing. Since its inception, Rosen Law Firm has obtained over $1 billion for shareholders.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
2 hours ago
- Business Wire
Rosen Law Firm Encourages Hims & Hers Health, Inc. Investors to Inquire About Securities Class Action Investigation
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Hims & Hers Health, Inc. (NYSE: HIMS) resulting from allegations that Hims & Hers may have issued materially misleading business information to the investing public. So What: If you purchased Hims & Hers securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. What to do next: To join the prospective class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@ for information on the class action. What is this about: On June 23, 2025, before the market opened, Novo Nordisk issued a press release entitled 'Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing.' The press release further stated that, in late April, 'the FDA resolved the Wegovy ® shortage based on its conclusion that Novo Nordisk is fully meeting current and projected nationwide demand for this medicine. In support of transitioning patients from knock-off compounded versions to authentic, FDA-approved Wegovy ® through NovoCare ® Pharmacy, Novo Nordisk began collaborating with telehealth companies. Over one month into the collaboration, Hims & Hers Health, Inc. has failed to adhere to the law which prohibits mass sales of compounded drugs under the false guise of 'personalization' and are disseminating deceptive marketing that put patient safety at risk.' On this news, Hims & Hers stock fell over 28% in intraday trading on June 23, 2025. Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Attorney Advertising. Prior results do not guarantee a similar outcome.
Miami Herald
5 hours ago
- Miami Herald
New to The Street Show #673 Airs Nationwide on Bloomberg TV - Saturday, June 21 at 6:30 PM EST Featuring FLOKI, NRX Pharmaceuticals (NASDAQ:NRXP), MUSQ - The Music ETF (NYSE:MUSQ), Health In Tech (NASDAQ:HIT), and Vita Bella
The show is sponsored by The Sustainable Green Team's (OTC:SGTM) Waterless Garden NEW YORK CITY, NY / ACCESS Newswire / June 20, 2025 / New to The Street, the nation's leading financial television series, announces the nationwide broadcast of Episode #673 on Saturday, June 21 at 6:30 PM EST across Bloomberg Television as sponsored programming. Sponsored by The Sustainable Green Team's (OTC PINK:SGTM) Waterless Garden, this week's show features five innovators from across the Web3, biotech, ETF, insurtech, and wellness industries. The program includes exclusive coverage of FLOKI's June 30 mainnet launch of Valhalla, one of the most anticipated metaverse game deployments in crypto. In addition to its national TV footprint, New to The Street also delivers major reach via its rapidly growing YouTube platform, New to The Street TV, which now has over 2.77 million subscribers and features full interviews and behind-the-scenes content: Featured Segments Include: FLOKI - The people's crypto shares key updates including the June 30 launch of Valhalla, its Norse mythology-based metaverse game, and continued growth of its no-code tokenization platform, Pharmaceuticals (NASDAQ:NRXP) - CEO Dr. Jonathan Javitt discusses progress on the company's FDA-designated drug candidates and its national rollout of interventional mental health services through HOPE - The Music ETF (NYSE:MUSQ) - The only ETF focused entirely on the music industry, MUSQ delivers a new opportunity for investors to gain exposure to global music In Tech (NASDAQ:HIT) - The insurtech company digitizing benefits through real-time quoting, advanced APIs, and simplified plan Bella - A wellness brand combining science-based skincare and nutrition for a premium, longevity-focused lifestyle product suite. New to The Street airs weekly on Bloomberg Television (Saturdays at 6:30 PM EST) and FOX Business (Mondays at 10:30 PM EST), reaching over 225 million homes and backed by outdoor Times Square billboards, earned media placement on ABC/NBC/CBS affiliates, and one of the fastest-growing business YouTube channels in the industry. About the Featured Companies About FLOKI FLOKI is the people's cryptocurrency and the utility token of the Floki Ecosystem, with over 550,000 holders worldwide. Built around utility, community, philanthropy, and marketing, FLOKI has launched campaigns seen by billions. The upcoming June 30, 2025 mainnet launch of Valhalla, its metaverse MMORPG, marks a milestone in its global | @RealFlokiInu About TokenFi TokenFi is a no-code platform empowering users to create and tokenize crypto and real-world assets with ease, targeting the multi-trillion-dollar asset tokenization | @tokenfi About Valhalla Valhalla is FLOKI's metaverse MMORPG where users explore, collect, and battle creatures called Veras in a decentralized, play-to-earn economy. The mainnet goes live June 30, About NRX Pharmaceuticals, Inc. (NASDAQ:NRXP) NRX Pharmaceuticals is developing NMDA-targeted therapeutics to treat CNS conditions including suicidal bipolar depression, PTSD, and chronic pain. Its lead drug, NRX-101, has FDA Breakthrough Therapy Designation and is moving toward accelerated approval. The company is also advancing NRX-100, a preservative-free ketamine formulation with Fast Track About HOPE Therapeutics, Inc. HOPE Therapeutics, a subsidiary of NRX Pharmaceuticals, is establishing a national network of clinics to deliver ketamine, TMS, and digital therapies for patients with suicidal depression and related About MUSQ - The Music ETF (NYSE:MUSQ) MUSQ offers diversified exposure to the global music economy, including streaming platforms, music publishers, labels, and live event companies-all in one About Health In Tech (NASDAQ:HIT) Health In Tech is a disruptive insurtech streamlining plan administration through real-time quoting tools, automation, and API-driven About Vita Bella Vita Bella is a premium wellness and skincare brand blending science and beauty through clean, longevity-driven formulations for skin and body About The Sustainable Green Team (OTC:SGTM) The Sustainable Green Team is an industry leader in environmentally responsible solutions. Its Waterless Garden system redefines landscaping through sustainable, soil-enhancing mulch that requires no irrigation-backed by proprietary soil tech and adopted across eco-conscious public and private Media Contact:Monica BrennanDirector of Media RelationsMonica@ Explore more: on YouTube (2.77M+ subscribers): SOURCE: New To The Street
Associated Press
5 hours ago
- Associated Press
Telvantis Inc. Closes May 25 With $20.6M+ in Revenue; Confirms Full Year Plan in Excess of $200M in Revenues and Strong Commercial Momentum
MIAMI BEACH, FL - June 23, 2025 ( NEWMEDIAWIRE ) - Telvantis Inc., (OTC: RDAR) ('Telvantis' or the 'Company'), a U.S.-based technology-driven telecommunications and enterprise solutions provider, today announced approximately $20.6 million in revenue in the month of May 2025, confirming strong recovery of the business. With a growing current run rate of approximately $20 million in monthly revenue, the company has substantially surpassed 2024 revenue performance. Importantly, the company's revenue trajectory continues to accelerate, validating Telvantis' position as an emerging force in the telecom technology space. The Company's gross margin totaled approximately $150 thousand for the month as the company's gross margin continues to expand as anticipated and generated an operating loss of approximately $227 thousand before financing costs. The gross profit is expected to expand, while costs are expected to decline over the coming quarters. May marks the strongest monthly performance for the company's gross margin year to date. The current Q2'25 performance for revenues, gross margins and operating profit represents a substantial improvement over the first quarter in 2025. Note that all mentioned numbers are unaudited. 'This month of May was strong and we believe that we will close June even stronger,' commented Daniel Contreras, CEO of Telvantis Inc. 'We are seeing a lot of commercial momentum right now,' added Contreras. 'We will also work with our auditors to provide reviewed H1'25 numbers after the close of the quarter,' added Conteras. About Telvantis Telvantis Inc., (OTC: RDAR) is a U.S.-based telecommunications company delivering advanced solutions to operators, enterprises, and network providers worldwide. Through its recent acquisitions of operations in the U.S. and Ireland, Telvantis has strategically expanded its portfolio to encompass cutting-edge 5G technologies, cloud-based communications platforms, and enterprise-grade services. This expansion, combined with a forward-thinking approach, positions Telvantis for accelerated growth and market leadership in the evolving telecommunications landscape. Forward-looking statements This press release contains forward-looking statements that involve risks and uncertainties. These statements reflect Telvantis' current expectations regarding future events and are based on management's beliefs and assumptions. Actual results could differ materially from those projected due to various factors, including market conditions, competition, and the successful integration of acquired operations. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Telvantis undertakes no obligation to update or revise any forward-looking statements, except as required by law. Investor Relations contact Telvantis Inc. 1680 Michigan Avenue, Suite 700 Miami Beach, FL 33139 Email: [email protected] View the original release on
